AstraZeneca shares sink 7% on report of historic $400 billion merger talks with Bristol Myers Squibb
AstraZeneca is in talks for a potential merger with Bristol Myers Squibb, which could create a $400 billion healthcare giant. Despite the talks, AstraZeneca'...